Study record
A mitochondrially encoded hormone ameliorates obesity and insulin resistance
Zarse K, Ristow M · Cell Metab · 2015
ReviewSeveralEvidence tier R
What this study reported
Commentary summarising the report that MOTS-c promotes biosynthesis of the AMP analogue AICAR, which activates AMPK. The authors frame this as a possible target for future metabolic and aging research.
Limitations
Short commentary with no new data; interpretation rests on a single preclinical discovery study.
Study record
| Study model | Review |
|---|---|
| Substance studied | SeveralMore than one of these is central to the paper (common for reviews). |
| Species | Not reported |
| System studied | Commentary on the discovery report of MOTS-c (Lee et al. 2015) |
| Population | Not reported |
| Design | Commentary |
| Sample size as reported | Not reported |
| Control group | Not reported |
| Route (data field only) | Not reported |
| Endpoints measured | AICAR biosynthesis; AMPK activation |
| Pathways measured | Folate cycle / purines / AICAR · AMPK signalling |
| Research areas | Metabolic · Aging |
| Evidence tier | R — Review (context, not evidence) |
| Publication types | Journal Article, Comment |
Appraisal
Each dimension is recorded separately and never combined into a single score. A study can be well controlled and still tell you little about people.
- Relevance to MOTS-c
- Direct
- Model applicability
- n/a
- Sample size
- n/a
- Controls
- n/a
- Outcome validity
- n/a
- Support for its own conclusion
- n/a
Provenance
- Bibliographic fields retrieved from PubMed E-utilities efetch (title, journal, date, authors, DOI) on 2026-11-11.
- Annotated from the published abstract.
- Editorial review: approved (2026-11-11).
- Classification follows the site methodology; the record describes the study, not what MOTS-c does in people.